Cargando…

Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review

BACKGROUND: The treatment of metastatic prostate cancer has been revolutionized with the advent of many targeted therapies, including immunotherapy. Pembrolizumab has demonstrated benefit in the treatment of certain patients with docetaxel-refractory metastatic castrate-resistant prostate cancer (mC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Idossa, Dame, Friedlander, Terence, Paller, Channing J., Ryan, Charles J., Borno, Hala T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301521/ https://www.ncbi.nlm.nih.gov/pubmed/35875156 http://dx.doi.org/10.3389/fonc.2022.910115

Ejemplares similares

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
por: Paller, Channing J, et al.
Publicado: (2011)

Outcomes From Cytotoxic Chemotherapy Following Progression on Immunotherapy in Metastatic Melanoma: An Institutional Case-Series
por: Gaughan, Elizabeth M., et al.
Publicado: (2022)

A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapy
por: Lozar, Taja, et al.
Publicado: (2021)

Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer
por: Jang, Albert, et al.
Publicado: (2020)

Applications for open access normalized synthesis in metastatic prostate cancer trials
por: Luechtefeld, Thomas, et al.
Publicado: (2022)

Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
por: Ollivier, Luc, et al.
Publicado: (2021)

A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy
por: Kim, Isaac, et al.
Publicado: (2021)

Complete remission with immunotherapy: Case report of a patient with metastatic bladder cancer to the humerus
por: Abdelhakam, D., et al.
Publicado: (2020)

A Review of Pomegranate in Prostate Cancer
por: Paller, Channing J., et al.
Publicado: (2017)

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports
por: Tucker, Matthew D., et al.
Publicado: (2020)

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
por: Xiang, Yongbo, et al.
Publicado: (2023)

Appendicitis: A rare case caused by metastatic prostate cancer
por: Khan, Khuram, et al.
Publicado: (2018)

Abscopal effect in metastatic breast cancer treated with stereotactic body radiotherapy in the absence of immunotherapy
por: Kim, Jae Sik, et al.
Publicado: (2023)

Toward Maximizing Immunotherapy in Metastatic Castration-Resistant Prostate Cancer – Rationale for Combinatorial Approaches Using Chemotherapy
por: Slovin, Susan R.
Publicado: (2012)

Multimodal therapy in the treatment of metastatic prostate cancer: A case report
por: Omidele, Olamide O., et al.
Publicado: (2018)

An Unusual Case of Metastatic Basal Cell Carcinoma of the Prostate: A Case Report and Literature Review
por: Dong, Shiqiang, et al.
Publicado: (2020)

Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature
por: Riviere, Paul, et al.
Publicado: (2021)

Case Report: First Case of Consolidation Immunotherapy After Definitive Chemoradiotherapy in Mediastinal Lymph Node Metastatic Sarcomatoid Carcinoma
por: Wang, Yu, et al.
Publicado: (2022)

Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller, Channing J, et al.
Publicado: (2012)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Perspectives on Immunotherapy of Metastatic Colorectal Cancer
por: Dai, Yongjiu, et al.
Publicado: (2021)

Case report: Incidental metastatic prostate cancer with undetectable PSA in pelvic lymphadenectomy
por: McLeay, Matthew T., et al.
Publicado: (2018)

Case report of metastatic prostate cancer to testicles: An ominous sign of advanced disease
por: Turk, Andrew, et al.
Publicado: (2019)

Radiotherapy combined with immunotherapy successfully treated one case of anaplastic thyroid cancer: A case report
por: Xing, Yurou, et al.
Publicado: (2023)

Larotrectinib in Mismatch-Repair-Deficient TRK Fusion-Positive Metastatic Colon Cancer After Progression on Immunotherapy
por: Kasi, Pashtoon M, et al.
Publicado: (2022)

Case Report: Tumor-to-tumor metastasis with prostate cancer metastatic to lung cancer: the first reported case
por: Liu, Shiyue, et al.
Publicado: (2023)

Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials
por: Schreiber, Anna R., et al.
Publicado: (2021)

The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy
por: Gou, Miaomiao, et al.
Publicado: (2021)

Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment
por: Sternberg, Cora N., et al.
Publicado: (2022)

Chemo-immunotherapy for metastatic non-squamous NSCLC in a patient with HIV infection: A case report
por: Inno, Alessandro, et al.
Publicado: (2023)

Past, Current, and Future of Immunotherapies for Prostate Cancer
por: Boettcher, Adeline N., et al.
Publicado: (2019)

Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review
por: Xie, Peiyi, et al.
Publicado: (2022)

Fever of unknown origin, a rare presentation of metastatic prostate cancer: Case report
por: Hota, Thiago, et al.
Publicado: (2020)

Case report of metastatic prostate cancer masquerading as squamous cell carcinoma on the tip of the penis
por: Russo, Nicholas W., et al.
Publicado: (2021)

The second docetaxel rechallenge for metastatic castration-resistant prostate cancer: a case report
por: Ning, Wei, et al.
Publicado: (2023)

Progression in immunotherapy for advanced prostate cancer
por: Liang, Hao, et al.
Publicado: (2023)

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer
por: Jindal, Tanya, et al.
Publicado: (2023)

Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
por: Forster, Stefan, et al.
Publicado: (2020)

Advanced diffuse hepatic angiosarcoma treated successfully with TACE and targeted immunotherapy: A case report
por: Lin, Yucheng, et al.
Publicado: (2023)

A Case Report of Metastatic Castration-Resistant Prostate Cancer Harboring a PTEN Loss
por: Myint, Zin W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q455ev0qafodlev1oresh7degk